{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:05:17Z","timestamp":1792202717392,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The crude mortality rate and the lifetime mortality risk from prostate cancer in Germany are above international average. However age-standardised mortality and years of life lost per capita from prostate cancer are declining. This study analyses the mortality-related measures for the federal state of North Rhine-Westphalia (NRW) in Germany.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on the cause of death statistics and data from the NRW State Cancer Registry on 45,300 deaths in the years 2007\u20132021, mortality rates, the lifetime mortality risk from prostate cancer, median age at death and years of life lost are presented. Additionally, the 15 most frequent causes of death of 95,013 patients diagnosed with prostate cancer are reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>With a stable lifetime mortality risk from prostate cancer, age-standardised mortality and years of life lost per capita are decreasing while crude mortality and median age at death are increasing in NRW. Less than half of the patients die from their prostate cancer. Cancers of the urinary bladder and other urinary organs also occur more frequently as a cause of death than it would be expected based on the age-specific risk in the total population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>More people in North Rhine-Westphalia are dying of prostate cancer over time due to demographic ageing alone. At the same time, the age-specific mortality risk has not increased and when patients die of prostate cancer, it is at an increasingly older age. However, there is a statistical association with deaths from cancers of the lower urinary tract in patients diagnosed with prostate cancer, which demands further evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-024-01564-y","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T13:03:00Z","timestamp":1724763780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mortality from prostate cancer in the years 2007\u20132021 in North Rhine-Westphalia, Germany"],"prefix":"10.1186","volume":"24","author":[{"given":"Kevin","family":"Claa\u00dfen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Karpinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiltraud","family":"Kaj\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"H\u00fcsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Wellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Hadaschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"1564_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA A Cancer J Clin"},{"key":"1564_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10:63\u201389. https:\/\/doi.org\/10.14740\/wjon1191.","journal-title":"World J Oncol."},{"key":"1564_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:778\u201389. https:\/\/doi.org\/10.1002\/ijc.33588.","journal-title":"Int J Cancer"},{"key":"1564_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-42769-0_1","volume-title":"Management of Prostate Cancer","author":"F Bray","year":"2017","unstructured":"Bray F, Kiemeney LA. Epidemiology of prostate cancer in europe: patterns, trends and determinants. In: Bolla M, van Poppel H, editors. Management of prostate cancer. Cham: Springer International Publishing; 2017. p. 1\u201327. https:\/\/doi.org\/10.1007\/978-3-319-42769-0_1."},{"key":"1564_CR5","volume-title":"Krebs in Deutschland f\u00fcr 2019\/2020","author":"C Ronckers","year":"2023","unstructured":"Ronckers C, Spix C, Tr\u00fcbenbach C, Katalinic A, Christ M, Cicero A, et al. Krebs in Deutschland f\u00fcr 2019\/2020. 14th ed. Berlin: Robert Koch-Institut; Gesellschaft der epidemiologischen Krebsregister; 2023.","edition":"14"},{"key":"1564_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.euo.2023.09.008","volume":"6","author":"A Krilaviciute","year":"2023","unstructured":"Krilaviciute A, Becker N, Lakes J, Radtke JP, Kuczyk M, Peters I, et al. Digital rectal examination is not a useful screening test for prostate cancer. Eur Urol Oncol. 2023;6:566\u201373. https:\/\/doi.org\/10.1016\/j.euo.2023.09.008.","journal-title":"Eur Urol Oncol"},{"key":"1564_CR7","unstructured":"Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975\u20132015, National Cancer Institute. 2018. https:\/\/seer.cancer.gov\/csr\/1975_2015\/. Accessed 5 Jul 2023."},{"key":"1564_CR8","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1158\/1055-9965.EPI-20-0782","volume":"29","author":"M Song","year":"2020","unstructured":"Song M, Hildesheim A, Shiels MS. Premature years of life lost due to cancer in the United States in 2017. Cancer Epidemiol Biomark Prev. 2020;29:2591\u20138. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-0782.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1564_CR9","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/pros.24360","volume":"82","author":"D Withrow","year":"2022","unstructured":"Withrow D, Pilleron S, Nikita N, Ferlay J, Sharma S, Nicholson B, et al. Current and projected number of years of life lost due to prostate cancer: a global study. Prostate. 2022;82:1088\u201397. https:\/\/doi.org\/10.1002\/pros.24360.","journal-title":"Prostate"},{"key":"1564_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3238\/arztebl.m2021.0148","volume":"118","author":"A Wengler","year":"2021","unstructured":"Wengler A, Rommel A, Pla\u00df D, Gruhl H, Leddin J, Ziese T, von der Lippe E. Years of life lost to death. Dtsch Arztebl Int. 2021;118:137\u201344. https:\/\/doi.org\/10.3238\/arztebl.m2021.0148.","journal-title":"Dtsch Arztebl Int"},{"key":"1564_CR11","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1002\/sim.7344","volume":"36","author":"H-J Kim","year":"2017","unstructured":"Kim H-J, Luo J, Chen H-S, Green D, Buckman D, Byrne J, Feuer EJ. Improved confidence interval for average annual percent change in trend analysis. Stat Med. 2017;36:3059\u201374. https:\/\/doi.org\/10.1002\/sim.7344.","journal-title":"Stat Med"},{"key":"1564_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ijc.2910020310","volume":"2","author":"R Doll","year":"1967","unstructured":"Doll R, Cook P. Summarizing indices for comparison of cancer incidence data. Int J Cancer. 1967;2:269\u201379.","journal-title":"Int J Cancer"},{"key":"1564_CR13","doi-asserted-by":"publisher","unstructured":"Fay MP. Estimating age conditional probability of developing disease from surveillance data. Popul Health Metrics. 2004;2:o. S. https:\/\/doi.org\/10.1186\/1478-7954-2-6.","DOI":"10.1186\/1478-7954-2-6"},{"key":"1564_CR14","volume-title":"DevCan: Probability of Developing or Dying of Cancer Software, Version 6.8.0","author":"National Cancer Institute","year":"2012","unstructured":"National Cancer Institute. DevCan: Probability of Developing or Dying of Cancer Software, Version 6.8.0. 2012."},{"key":"1564_CR15","unstructured":"IT.NRW. Sterbetafel: Durchschnittliche Lebenserwartung in Jahren nach Geschlecht und vollendetem Alter. 2022. https:\/\/www.landesdatenbank.nrw.de\/ldbnrw\/online. Accessed 5 Jul 2023."},{"key":"1564_CR16","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ. 1987:(82):1\u2013406."},{"key":"1564_CR17","unstructured":"IT.NRW. Im Jahr 2021 sind in NRW 67,7 Prozent mehr Menschen an COVID-19 gestorben als 2020. 2022. https:\/\/www.it.nrw\/im-jahr-2021-sind-nrw-677-prozent-mehr-menschen-covid-19-gestorben-als-2020-18387. Accessed 5 Jul 2023."},{"key":"1564_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3816\/CGC.2004.n.016","volume":"3","author":"Y Kinoshita","year":"2004","unstructured":"Kinoshita Y, Singh A, Rovito PM, Wang CY, Haas GP. Double primary cancers of the prostate and bladder: a literature review. Clin Prostate Cancer. 2004;3:83\u20136. https:\/\/doi.org\/10.3816\/CGC.2004.n.016.","journal-title":"Clin Prostate Cancer"},{"key":"1564_CR19","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.ejso.2017.08.013","volume":"43","author":"R Malte","year":"2017","unstructured":"Malte R, Kluth LA, Kaushik D, Boorjian SA, Abufaraj M, Foerster B, et al. Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: results from an international retrospective study. Eur J Surg Oncol. 2017;43:2193\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2017.08.013.","journal-title":"Eur J Surg Oncol"},{"key":"1564_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.eururo.2007.07.002","volume":"52","author":"PJ Bostrom","year":"2007","unstructured":"Bostrom PJ, Soloway MS. Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk? Eur Urol. 2007;52:973\u201382. https:\/\/doi.org\/10.1016\/j.eururo.2007.07.002.","journal-title":"Eur Urol"},{"key":"1564_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.eururo.2018.09.034","volume":"75","author":"M Moschini","year":"2019","unstructured":"Moschini M, Zaffuto E, Karakiewicz PI, Andrea DD, Foerster B, Abufaraj M, et al. External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: a population-based analysis. Eur Urol. 2019;75:319\u201328. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.034.","journal-title":"Eur Urol"},{"key":"1564_CR22","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.juro.2008.07.038","volume":"180","author":"AM Nieder","year":"2008","unstructured":"Nieder AM, Porter MP, Soloway MS. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. J Urol. 2008;180:2005\u201310. https:\/\/doi.org\/10.1016\/j.juro.2008.07.038.","journal-title":"J Urol"},{"key":"1564_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.euros.2024.02.013","volume":"63","author":"C McPartland","year":"2024","unstructured":"McPartland C, Salib A, Banks J, Mark JR, Lallas CD, Trabulsi EJ, et al. Risk of secondary malignancies after pelvic radiation: a population-based analysis. Eur Urol Open Sci. 2024;63:52\u201361. https:\/\/doi.org\/10.1016\/j.euros.2024.02.013.","journal-title":"Eur Urol Open Sci"},{"key":"1564_CR24","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ijrobp.2011.08.034","volume":"83","author":"MJ Zelefsky","year":"2012","unstructured":"Zelefsky MJ, Housman DM, Pei X, Alicikus Z, Magsanoc JM, Dauer LT, et al. Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;83:953\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.08.034.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1564_CR25","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.230237","author":"JH Kim","year":"2024","unstructured":"Kim JH, Bae GH, Jung J, Noh TI. Secondary cancer after androgen deprivation therapy in prostate cancer: a nationwide study. World J Mens Health. 2024. https:\/\/doi.org\/10.5534\/wjmh.230237.","journal-title":"World J Mens Health"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01564-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-024-01564-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01564-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T13:04:33Z","timestamp":1724763873000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-024-01564-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1564"],"URL":"https:\/\/doi.org\/10.1186\/s12894-024-01564-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4553645\/v1","asserted-by":"object"}]},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"9 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate are deemed unnecessary according to national regulations, i.e. Section\u00a065c of the Fifth Book of the German Social Code in conjunction with the elaborations of the NRW State Cancer Register Act (LKRG NRW).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable due to data aggregation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}